Search for: "Pfizer, Incorporated" Results 81 - 100 of 134
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2011, 12:27 pm by Ron
[Pfizer also won a place for its alliance of 19 firms that do 75% of the company’s work at fixed fees. [read post]
27 Jun 2011, 11:47 am by Stephen Albainy-Jenei
pricing debate (Roche vs Cipla), Compulsory Licensing: Export of patented drugs (Pfizer/ Roche vs Natco), Linkages in Indian Patent System (Custom enforcement, Biopharmaceuticals, Marketing –Approval and EMR, Efficacy testing, Competition, Working). [read post]
6 May 2011, 11:02 am by Rebecca Tushnet
Pfizer is now talking about its open innovation practices. [read post]
3 May 2011, 7:16 am by Zoe Tillman
Pfizer has held exclusive rights to Lipitor for 15 years, according to Boasberg’s opinion. [read post]
4 Apr 2011, 9:01 pm
 Haroff concluded by urging that regulators incorporate the precautionary principle in their PRA. [read post]
23 Feb 2011, 9:20 am
  Bruesewitz involved a diphtheria-tetanus-pertussis (DTP) vaccine, Tri-Immunol, formerly manufactured by Lederle (later acquired by Wyeth, and subsequently, Pfizer). [read post]
16 Feb 2011, 1:37 pm by Ashley S. Miller
  Acumen seeks to incorporate environmental sustainability into its redevelopment projects, and is known for constructing a rooftop farm comprising 43,000 square feet on another former industrial property in Long Island City. [read post]
11 Nov 2010, 6:00 am
" According to minutes released by FDA from a recent PDUFA reauthorization negotiation session held October 25, 2010, the idea of incorporating a four-phase review process has been dropped. [read post]
30 Sep 2010, 5:58 am by David G. Badertscher
In the past, Roberts has not taken part in cases involving Pfizer because he owned less than $15,000 of the company's stock. [read post]
27 Aug 2010, 2:41 pm by Bexis
In the last month, we’ve seen two more appellate decisions definitively rejecting the idea of some sort of separate cause of action – apart from warning or design defect – for “failure to test,” whatever that might be. [read post]
14 Aug 2010, 5:02 am by Rebecca Tushnet
Copyright Track ISPs and Takedown Notices Peter Yu, Drake University Law School The Graduated Response Copyright holders think that infringement makes ISPs more money by enhancing demand; so they should share the responsibility. [read post]
12 Aug 2010, 3:50 pm by Francis G.X. Pileggi
  Importantly, this plurality plus policy was adopted by board resolution, as distinguished from being adopted by either a bylaw or as part of the Certificate of Incorporation. [read post]
30 Jun 2010, 9:01 am by Matthew Scarola
The Court declined to grant certiorari in Pfizer, Inc. v. [read post]
10 Jun 2010, 3:58 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: Biogen launches submarine patent against competing providers of Interferon-Beta products (Holman's Biotech IP Blog)(Patent Docs) (Patent Docs)   General Drug access waiver debate looms for June TRIPS Council Meeting (IP Watch) Worning named acting head of WHO IP Division (IP Watch) Australian Senate to release gene… [read post]
24 May 2010, 8:24 am
However, realizing that private individuals would need some incentive to do so, a relator’s share provision was incorporated into the statute. [read post]
18 May 2010, 5:01 am by J Robert Brown Jr.
  Had Occidental been incorporated in Britain and complying with the Combined Code, the compensation committee would not have been considered independent. [read post]
9 Mar 2010, 6:47 am by Jay Willis
  At the BLT, Tony Mauro notes that Chief Justice Roberts – who owns Pfizer/Wyeth stock – recused himself from the decision to grant cert. in the case. [read post]